HemoSense to Hold Fiscal 2007 Third Quarter Financial Results Conference Call on August 7.SAN JOSE San Jose, city, United States San Jose (sănəzā`, săn hōzā`), city (1990 pop. 782,248), seat of Santa Clara co., W central Calif.; founded 1777, inc. 1850. , Calif. -- HemoSense, Inc. (AMEX AMEX See: American Stock Exchange :HEM) today announced that it will release financial results for the three and nine months ended June 30, 2007 after market close on Tuesday, August 7, 2007. HemoSense management will host an investment community conference call beginning at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss those results and answer questions. Individuals interested in participating in the conference call may do so by dialing (877) 815-7177 for domestic callers, or (706) 634-1178 for international callers. Those interested in listening to the conference call live via the Internet may do so by visiting the Investors section of the company's Web site at www.hemosense.com. A telephone replay will be available for 48 hours following the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers, and entering reservation code 11125928. A webcast replay will be available for 30 days by visiting the Investors section on the HemoSense Web site. About HemoSense HemoSense is a point-of-care diagnostic healthcare company that initially has developed, manufactures and commercializes easy-to-use, handheld blood coagulation Noun 1. blood coagulation - a process in which liquid blood is changed into a semisolid mass (a blood clot) blood clotting clotting, coagulation, curdling - the process of forming semisolid lumps in a liquid systems for monitoring patients taking warfarin warfarin (wôr`fərĭn), anticoagulant used to treat blood clots. In large doses it causes bleeding. Warfarin, mixed with bait, is used in rodent control. warfarin Anticoagulant drug, marketed as Coumadin. . The HemoSense INRatio[R] system, used by healthcare professionals and patients themselves, consists of a small monitor and disposable test strips. It provides accurate and convenient measurement of blood clotting blood clotting, process by which the blood coagulates to form solid masses, or clots. In minor injuries, small oval bodies called platelets, or thrombocytes, tend to collect and form plugs in blood vessel openings. time, or PT/INR values. Routine measurements of PT/INR are necessary for the safe and effective management of the patient's warfarin dosing. INRatio is sold in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and internationally. For more information, visit www.hemosense.com. HemoSense[R] and INRatio[R] are registered trademarks of HemoSense, Inc. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion